Search This Blog

Thursday, August 8, 2019

Autolus Therapeutics EPS beats by $0.11

Autolus Therapeutics (NASDAQ:AUTL): Q2 GAAP EPS of -$0.65 beats by $0.11.
Revenue of $0.34M (-22.7% Y/Y)
Cash of $266.19M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)